跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
APX-ROXITHROMYCIN roxithromycin 150 mg tablet blister pack
Approved
STANDARD
APX-ROXITHROMYCIN roxithromycin 150 mg tablet blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
74f64ce6550d14c7
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
74f64ce6550d14c7
Product Name
APX-ROXITHROMYCIN roxithromycin 150 mg tablet blister pack
Artg Id
333544
Artg Name
APX-ROXITHROMYCIN roxithromycin150 mg tablet blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2020-05-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/af6016fd1a3c4be88f6135bcbcbf9528.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/b1e1cc88b01a066a113cf6872428f15a.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
74f64ce6550d14c7
Type
Standard
Back to TGA Approvals
APX-ROXITHROMYCIN roxithromycin 150 mg tablet blister pack - TGA Drug Approval Details